spacer
home > pmps > spring 2019 > pharmaceutical fraud
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmaceutical Fraud

In 2011, a man was jailed for eight years for conducting counterfeit medicine fraud that amounted to a retail value of £4.7 million. As a result of him being able to infiltrate the pharmaceutical supply chain, 25,000 packets of counterfeit medication reached pharmacies and patients all over the UK. These knock-off tablets were used to treat heart disease, pancreatic cancer, and mental illnesses and had none, or only part, of the active ingredient they were supposed to contain. Sadly, this meant that those people’s illnesses were left to take their course.

Unfortunately, while tremendous effort goes into ensuring the effective operation of every pharma supply chain, the losses are staggering. With the global counterfeit drug market worth £154 billion and one million people dying due to fake medicine around the world each year, a reliable supply chain is paramount. Enter: blockchain. While blockchain harnesses a plethora of benefits, addressing its shortcomings is necessary to ensure that implementation of the technology can be utilised to its full effect.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Karim Jawhary is the Senior Industry Director of Life Sciences and Healthcare at Unisys. He brings over 15 years’ experience to the technology industry, with deep expertise in cloud computing, Software-as-a- Service, Big Data, and security solutions. Prior to joining Unisys, Karim served at TIBCO Software as a Senior Account Executive, leveraging the TIBCO connected intelligence cloud to augment business intelligence and agility through analytical insights. He also worked at Akamai Technologies as an Enterprise Account Executive where he built a strong life sciences and healthcare practice. Karim holds a bachelor’s degree in business management from East Stroudsburg University of Pennsylvania, US, and has pursued continuing education in force management, Miller Heiman strategic selling, and Sales Performance International solution selling.
spacer
Karim Jawhary
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Appoints Lawrence Miller as Chief Technology Officer

LONDON & PHILADELPHIA – June 13, 2019: Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services. An accomplished innovator, Miller brings unique vision and expertise to a Signant team already committed to advancing clinical research with its next-generation technology portfolio.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement